TapewireFind a company

person · Reporting owner

Paul David C

Disclosed activity across 1 company

Tapewire entity
68880
SEC CIK
0001555391

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
GLOBUS MEDICAL INCGMED · Entity 3496Director · Executive Chairman · 10% ownerJanuary 21, 2026January 23, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

GLOBUS MEDICAL INC

Report date January 21, 2026 · Filed January 23, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $94.15 · Expires 2036-01-21Direct100,000 Reported balance After 2026-01-21 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-01-21 · Grant · Acquired 100,000 · Balance 100,000

F1: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, then 1/48 of the options vesting each month thereafter.

Filing footnotes · ownership attribution and instrument terms

F1: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, then 1/48 of the options vesting each month thereafter.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
January 21, 2026 Filed Jan 23, 2026 22:03 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 100,000 $0.00 Strike: $94.15 $0.00
Disclosure

SEC source: 0001193125-26-021239 · ownership.xml · derivative · entry 1

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2036-01-21

F1 · derivative.exercise_date: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, then 1/48 of the options vesting each month thereafter.

Read SEC document
December 08, 2025 Filed Dec 10, 2025 21:37 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 34,375 $0.00 Strike: $25.52 $0.00
Disclosure

SEC source: 0001193125-25-314329 · ownership.xml · derivative · entry 2

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 34,375 shares

Expires 2026-01-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options were granted on January 25, 2016 and are fully vested.

Read SEC document
December 08, 2025 Filed Dec 10, 2025 21:37 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 34,375 $25.52 $877,250.00
Disclosure

SEC source: 0001193125-25-314329 · ownership.xml · nonDerivative · entry 1

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,417

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 23, 2025 Filed Mar 28, 2025 23:04 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 75,000 $0.00 Strike: $92.42 $0.00
Disclosure

SEC source: 0000950170-25-047036 · ownership.xml · derivative · entry 1

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Class A Common Stock · 75,000 shares

Expires 2035-01-23

F1 · derivative.exercise_date: These options were granted on January 23, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
November 15, 2024 Filed Nov 20, 2024 21:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 26,042 $0.00 Strike: $24.10 $0.00
Disclosure

SEC source: 0000950170-24-129270 · ownership.xml · derivative · entry 2

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 26,042 shares

Expires 2025-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options were granted on January 20, 2015 and are fully vested.

Read SEC document
November 15, 2024 Filed Nov 20, 2024 21:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 26,042 $24.10 $627,612.20
Disclosure

SEC source: 0000950170-24-129270 · ownership.xml · nonDerivative · entry 1

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,042

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 26, 2024 Filed Jan 30, 2024 21:33 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 75,000 $0.00 Strike: $53.75 $0.00
Disclosure

SEC source: 0000950170-24-008878 · ownership.xml · derivative · entry 1

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Class A Common Stock · 75,000 shares

Expires 2034-01-26

F1 · derivative.exercise_date: These options were granted on January 26, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
December 05, 2023 Filed Dec 7, 2023 22:06 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GiftClass B Common Stock · Derivative 171,100 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-068856 · ownership.xml · derivative · entry 3

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Sonali Paul Children's Irrevocable Trust

Disclosed balance after: 171,100

Underlying: Class A Common Stock · 171,100 shares

Expires not disclosed

F1 · derivative.exercise_price: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.

F2 · kind: This transaction involved a gift by the reporting person and his spouse of a total of 342,200 shares of Class B Common Stock to trusts for the benefit of their children.

F1 · derivative.exercise_date: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.

F1 · derivative.expiration_date: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.

F4 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust.

Read SEC document
December 05, 2023 Filed Dec 7, 2023 22:06 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GiftClass B Common Stock · Derivative 171,100 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-068856 · ownership.xml · derivative · entry 2

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By The David C. Paul Children's Trust

Disclosed balance after: 171,100

Underlying: Class A Common Stock · 171,100 shares

Expires not disclosed

F1 · derivative.exercise_price: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.

F2 · kind: This transaction involved a gift by the reporting person and his spouse of a total of 342,200 shares of Class B Common Stock to trusts for the benefit of their children.

F1 · derivative.exercise_date: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.

F1 · derivative.expiration_date: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.

F3 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
December 05, 2023 Filed Dec 7, 2023 22:06 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GiftClass B Common Stock · Derivative 342,200 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-068856 · ownership.xml · derivative · entry 1

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,525,324

Underlying: Class A Common Stock · 342,200 shares

Expires not disclosed

F1 · derivative.exercise_price: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.

F2 · kind: This transaction involved a gift by the reporting person and his spouse of a total of 342,200 shares of Class B Common Stock to trusts for the benefit of their children.

F1 · derivative.exercise_date: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.

F1 · derivative.expiration_date: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.

Read SEC document
January 26, 2023 Filed Feb 27, 2023 21:50 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 75,000 $0.00 Strike: $75.18 $0.00
Disclosure

SEC source: 0001209191-23-013213 · doc4.xml · derivative · entry 1

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Class A Common Stock · 75,000 shares

Expires 2033-01-26

F1 · derivative.exercise_date: These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 21:37 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 75,000 $0.00 Strike: $63.68 $0.00
Disclosure

SEC source: 0001209191-22-005571 · doc4.xml · derivative · entry 1

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Class A Common Stock · 75,000 shares

Expires 2032-01-27

F1 · derivative.exercise_date: These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
January 14, 2021 Filed Jan 19, 2021 21:39 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 100,000 $0.00 Strike: $65.05 $0.00
Disclosure

SEC source: 0001209191-21-004030 · doc4.xml · derivative · entry 1

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2031-01-14

F1 · derivative.exercise_date: These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
January 22, 2020 Filed Jan 24, 2020 21:37 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 100,000 $0.00 Strike: $53.27 $0.00
Disclosure

SEC source: 0001209191-20-004841 · doc4.xml · derivative · entry 1

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2030-01-22

F1 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
January 22, 2019 Filed Feb 11, 2019 21:44 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 100,000 $0.00 Strike: $43.58 $0.00
Disclosure

SEC source: 0001209191-19-008984 · doc4.xml · derivative · entry 1

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2029-01-22

F1 · derivative.exercise_date: These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
September 25, 2018 Filed Sep 27, 2018 00:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 ConversionClass B Common Stock · Derivative 748,845 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-052374 · doc4.xml · derivative · entry 13

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,867,524

Underlying: Class A Common Stock · 748,845 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.

F3 · derivative.exercise_price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F3 · shares: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F3 · derivative.exercise_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F3 · derivative.expiration_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

Read SEC document
September 25, 2018 Filed Sep 27, 2018 00:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 748,845 $54.70 $40,959,125.66
Disclosure

SEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 9

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $55.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4.

Read SEC document
September 25, 2018 Filed Sep 27, 2018 00:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 ConversionClass A Common Stock 748,845 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 8

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 748,845

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 ConversionClass B Common Stock · Derivative 101,320 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-052374 · doc4.xml · derivative · entry 12

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,616,369

Underlying: Class A Common Stock · 101,320 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.

F3 · derivative.exercise_price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F3 · shares: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F3 · derivative.exercise_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F3 · derivative.expiration_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 ConversionClass B Common Stock · Derivative 298,647 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-052374 · doc4.xml · derivative · entry 11

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Sonali Paul Children's Trust

Disclosed balance after: 0

Underlying: Class A Common Stock · 298,647 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.

F3 · derivative.exercise_price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F3 · shares: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F3 · derivative.exercise_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F3 · derivative.expiration_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F5 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 ConversionClass B Common Stock · Derivative 298,647 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-052374 · doc4.xml · derivative · entry 10

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By David C. Paul Children's Trust

Disclosed balance after: 0

Underlying: Class A Common Stock · 298,647 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.

F3 · derivative.exercise_price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F3 · shares: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F3 · derivative.exercise_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F3 · derivative.expiration_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F4 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 101,320 $54.01 $5,472,556.63
Disclosure

SEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 7

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 ConversionClass A Common Stock 101,320 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 6

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,320

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 298,647 $54.01 $16,130,700.95
Disclosure

SEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 5

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Sonali Paul Children's Trust

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

F5 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 ConversionClass A Common Stock 298,647 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 4

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Sonali Paul Children's Trust

Disclosed balance after: 298,647

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F5 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 298,647 $54.01 $16,130,700.95
Disclosure

SEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 3

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By David C. Paul Children's Trust

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

F4 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 ConversionClass A Common Stock 298,647 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 2

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By David C. Paul Children's Trust

Disclosed balance after: 298,647

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.

F4 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 24, 2018 Filed Sep 27, 2018 00:15 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 605,871 $54.01 $32,724,667.97
Disclosure

SEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 1

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
July 17, 2018 Filed Jul 20, 2018 00:16 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 6,841 $52.95 $362,230.95
Disclosure

SEC source: 0001209191-18-043403 · doc4.xml · nonDerivative · entry 1

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 605,871

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

Read SEC document
April 30, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 72,938 $51.81 $3,778,574.97
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 21

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 612,712

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $51.935, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.

Read SEC document
April 27, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 29,066 $51.78 $1,505,127.58
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 20

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 685,650

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $51.8558, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 43,750 $0.00 Strike: $26.27 $0.00
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 30

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,250

Underlying: Class A Common Stock · 43,750 shares

Expires 2027-01-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F13 · derivative.exercise_date: These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 40,625 $0.00 Strike: $25.52 $0.00
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 29

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,375

Underlying: Class A Common Stock · 40,625 shares

Expires 2026-01-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 98,958 $0.00 Strike: $24.10 $0.00
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 28

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,042

Underlying: Class A Common Stock · 98,958 shares

Expires 2025-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_date: These options were granted on January 20, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 60,000 $0.00 Strike: $23.95 $0.00
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 27

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 60,000 shares

Expires 2024-01-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: These options were granted on January 23, 2014, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 48,000 $0.00 Strike: $13.04 $0.00
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 26

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 48,000 shares

Expires 2023-01-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: These options were granted on January 24, 2013, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 15,000 $0.00 Strike: $15.34 $0.00
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 25

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 15,000 shares

Expires 2022-08-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: These options were granted on August 29, 2012, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 18,461 $0.00 Strike: $10.66 $0.00
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 24

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 18,461 shares

Expires 2021-10-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: These options were granted on October 27, 2011, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 18,461 $0.00 Strike: $11.86 $0.00
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 23

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 18,461 shares

Expires 2020-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: These options were granted on June 16, 2010, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2011, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 18,461 $0.00 Strike: $4.88 $0.00
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 22

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 18,461 shares

Expires 2019-08-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 363,284 $51.81 $18,820,581.53
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 19

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 714,716

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 43,750 $51.81 $2,266,547.50
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 18

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,078,000

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 43,750 $26.27 $1,149,312.50
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 17

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,121,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 40,625 $51.81 $2,104,651.25
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 16

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,078,000

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 40,625 $25.52 $1,036,750.00
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 15

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,118,625

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 98,958 $51.81 $5,126,697.31
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 14

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,078,000

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 98,958 $24.10 $2,384,887.80
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 13

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,176,958

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 60,000 $51.81 $3,108,408.00
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 12

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,078,000

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 60,000 $23.95 $1,437,000.00
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 11

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,138,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 26, 2018 Filed May 1, 2018 00:59 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 48,000 $51.81 $2,486,726.40
Disclosure

SEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 10

Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,078,000

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.